Taiwan FDA registration e57c3a323da6150b5bd4b9c320f39c9e
“LIAISON” XL analyzer (Non-Sterile)
TW: “禮亞尚” 全自動冷光免疫分析儀(未滅菌)
Taiwan·Risk Class 1·MD·DIASORIN S.P.A.·Registered Jul 30, 2020 – Jul 30, 2025CancelledRegistration details
- Analysis ID
- e57c3a323da6150b5bd4b9c320f39c9e
- License Form
- Ministry of Health Medical Device Import No. 021801
- Customs Code
- DHA09402180101
Company information
- Manufacturer
- DIASORIN S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A2160 Individual photometric chemistry analyzer for clinical use
- Import Information
- Imported from abroad; GMP
Dates and status
- Registration Date
- Jul 30, 2020
- Expiry Date
- Jul 30, 2025
Cancellation information
- Status
- Logged out
- Reason
- 轉為登錄字號
About this record
Access comprehensive regulatory information for “LIAISON” XL analyzer (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number e57c3a323da6150b5bd4b9c320f39c9e and manufactured by DIASORIN S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices